3-(4-methoxyphenyl)-5-({[4-(4-methoxyphenyl)-5-methyl-4h-1,2,4-triazol-3-yl]sulfanyl}methyl)-1,2,4-oxadiazole (34M) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.11
Number of clusters 31
Number of clusters representing 95% 9
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.6141
ΔGstrain (kcal/mol) 0.6309
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 1901 0 1.2349
2 1674 0.0753 1.995
3 1523 0.1312 1.7094
4 1074 0.3381 1.6277
5 939 0.4176 2.3966
6 856 0.4724 1.827
7 738 0.5603 2.5089
8 655 0.6309 0.8123
9 442 0.8638 2.5129
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)